If you could vote on Brexit now which option would you choose?
   

Italy to enter capital of ReiThera to support COVID vaccine development


Italy will invest in local biotech company ReiThera to support the development of its COVID-19 vaccine, a senior official said on Tuesday after the government called results of a Phase 1 trial encouraging. ReiThera is developing the vaccine with Germany’s Leukocare and Belgium’s Univercells and started talks with the European Union in September about supplying the bloc with doses. An initial trial involved 45 volunteers aged between 18 and 55. None of them showed serious side effects in the 28 days after the vaccination, said Giuseppe Ippolito, scientific director of Rome’s Lazzaro Spallanzani institute which conducted the tests.

Reuters India - January 5, 2021

View the full story here: https://uk.reuters.com/article/us-health-coronavirus-italy-reithera/italy-to-enter-capital-of-reithera-to-support-covid-vaccine-development-idUKKBN29A17V